Regulation	O
of	O
jun	O
and	O
fos	O
gene	O
expression	O
in	O
human	B-cell_type
monocytes	I-cell_type
by	O
the	O
macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
.	O

The	O
macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	O
M-CSF	B-protein
)	O
is	O
required	O
for	O
the	O
growth	O
and	O
differentiation	O
of	O
mononuclear	B-cell_type
phagocytes	I-cell_type
.	O

However	O
,	O
the	O
signaling	O
events	O
responsible	O
for	O
these	O
effects	O
remain	O
unclear	O
.	O

The	O
present	O
studies	O
have	O
examined	O
the	O
effects	O
of	O
M-CSF	B-protein
on	O
potential	O
signaling	O
pathways	O
involving	O
expression	O
of	O
the	O
jun	B-DNA
and	I-DNA
fos	I-DNA
early	I-DNA
response	I-DNA
genes	I-DNA
.	O

Low	O
levels	O
of	O
c-jun	B-protein
transcripts	I-protein
were	O
detectable	O
in	O
resting	B-cell_type
human	I-cell_type
peripheral	I-cell_type
blood	I-cell_type
monocytes	I-cell_type
.	O

Treatment	O
of	O
these	O
cells	O
with	O
10	O
(	O
3	O
)	O
units/ml	O
human	B-protein
recombinant	I-protein
M-CSF	I-protein
was	O
associated	O
with	O
rapid	O
and	O
transient	O
increases	O
in	O
c-jun	B-RNA
mRNA	I-RNA
levels	O
.	O

Nuclear	O
run-on	O
assays	O
and	O
mRNA	O
stability	O
studies	O
demonstrated	O
that	O
M-CSF	B-protein
regulates	O
c-jun	B-DNA
expression	O
by	O
both	O
an	O
increase	O
in	O
transcription	O
rate	O
and	O
a	O
prolongation	O
in	O
the	O
half-life	O
of	O
c-jun	B-RNA
transcripts	I-RNA
.	O

M-CSF	B-protein
treatment	O
was	O
also	O
associated	O
with	O
a	O
rapid	O
induction	O
of	O
the	O
jun-B	B-DNA
gene	I-DNA
,	O
although	O
expression	O
of	O
this	O
gene	O
was	O
prolonged	O
compared	O
to	O
that	O
of	O
c-jun	B-DNA
.	O

We	O
further	O
demonstrate	O
that	O
M-CSF	B-protein
increases	O
c-fos	B-RNA
mRNA	I-RNA
levels	O
in	O
human	B-cell_type
monocytes	I-cell_type
through	O
control	O
at	O
both	O
the	O
transcriptional	O
and	O
posttranscriptional	O
levels	O
.	O

Maximal	O
induction	O
of	O
the	O
c-fos	B-DNA
gene	I-DNA
was	O
followed	O
by	O
that	O
for	O
the	O
fos-B	B-DNA
gene	I-DNA
.	O

Moreover	O
,	O
M-CSF	B-protein
-induced	O
expression	O
of	O
the	O
fos-related	B-DNA
gene	I-DNA
,	O
fra-1	B-DNA
,	O
was	O
delayed	O
compared	O
to	O
that	O
for	O
both	O
c-fos	B-DNA
and	O
fos-B	B-DNA
.	O

Taken	O
together	O
,	O
the	O
results	O
indicate	O
that	O
M-CSF	B-protein
treatment	O
is	O
associated	O
with	O
differential	O
activation	O
of	O
multiple	O
members	O
of	O
the	O
jun/fos	B-DNA
family	I-DNA
and	O
that	O
expression	O
of	O
these	O
genes	O
could	O
contribute	O
to	O
nuclear	O
signaling	O
mechanisms	O
that	O
regulate	O
a	O
specific	O
program	O
of	O
monocyte	O
differentiation	O
.	O

Vol	NULL
.	NULL

2	NULL
,	NULL
267-272	NULL
,	NULL
June	NULL
1991	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
267	NULL
Reig-Iulation	NULL
of	NULL
jun	NULL
and	NULL
fos	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
Monocytes	NULL
by	NULL
the	NULL
Macrophage	NULL
Colony-stimulating	NULL
Factor	NULL
'	NULL
Takashi	NULL
Nakamura	NULL
,	NULL
Rakesh	NULL
Datta	NULL
,	NULL
Surender	NULL
Kharbanda	NULL
,	NULL
and	NULL
Donald	NULL
Kufe	NULL
``	NULL
Laboratory	NULL
of	NULL
Clinical	NULL
Pharmacology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Abstract	NULL
The	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
M-CSF	NULL
)	NULL
is	NULL
required	NULL
for	NULL
the	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

However	NULL
,	NULL
the	NULL
signaling	NULL
events	NULL
responsible	NULL
for	NULL
these	NULL
effects	NULL
remain	NULL
unclear	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
have	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
M-CSF	NULL
on	NULL
potential	NULL
signaling	NULL
pathways	NULL
involving	NULL
expression	NULL
of	NULL
the	NULL
jun	NULL
and	NULL
fos	NULL
early	NULL
response	NULL
genes	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
c-jun	NULL
transcripts	NULL
were	NULL
detectable	NULL
in	NULL
resting	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

Treatment	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
10Â°	NULL
units/ml	NULL
human	NULL
recombinant	NULL
M-CSF	NULL
was	NULL
associated	NULL
with	NULL
rapid	NULL
and	NULL
transient	NULL
increases	NULL
in	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
.	NULL

Nuclear	NULL
run-on	NULL
assays	NULL
and	NULL
mRNA	NULL
stability	NULL
studies	NULL
demonstrated	NULL
that	NULL
M-CSF	NULL
regulates	NULL
c-jun	NULL
expression	NULL
by	NULL
both	NULL
an	NULL
increase	NULL
in	NULL
transcription	NULL
rate	NULL
and	NULL
a	NULL
prolongation	NULL
in	NULL
the	NULL
half-life	NULL
of	NULL
c-jun	NULL
transcripts	NULL
.	NULL

M-CSF	NULL
treatment	NULL
was	NULL
also	NULL
associated	NULL
with	NULL
a	NULL
rapid	NULL
induction	NULL
of	NULL
the	NULL
jun-B	NULL
gene	NULL
,	NULL
although	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
was	NULL
prolonged	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
c-jun	NULL
.	NULL

We	NULL
further	NULL
demonstrate	NULL
that	NULL
M-CSF	NULL
increases	NULL
c-fos	NULL
mRNA	NULL
levels	NULL
in	NULL
human	NULL
monocytes	NULL
through	NULL
control	NULL
at	NULL
both	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
levels	NULL
.	NULL

Maximal	NULL
induction	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
was	NULL
followed	NULL
by	NULL
that	NULL
for	NULL
the	NULL
fos-B	NULL
gene	NULL
.	NULL

Moreover	NULL
,	NULL
M-CSF-induced	NULL
expression	NULL
of	NULL
the	NULL
fos-related	NULL
gene	NULL
,	NULL
fra-1	NULL
,	NULL
was	NULL
delayed	NULL
compared	NULL
to	NULL
that	NULL
for	NULL
both	NULL
c-fos	NULL
and	NULL
fos-B	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
results	NULL
indicate	NULL
that	NULL
M-CSF	NULL
treatment	NULL
is	NULL
associated	NULL
with	NULL
differential	NULL
activation	NULL
of	NULL
multiple	NULL
members	NULL
of	NULL
the	NULL
jun/	NULL
fos	NULL
family	NULL
and	NULL
that	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
could	NULL
contribute	NULL
to	NULL
nuclear	NULL
signaling	NULL
mechanisms	NULL
that	NULL
regulate	NULL
a	NULL
specific	NULL
program	NULL
of	NULL
monocyte	NULL
differentiation	NULL
.	NULL

Introduction	NULL
The	NULL
M-CSP	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
survival	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
M-CSF	NULL
receptor	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-fms	NULL
protooncogene	NULL
and	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
glycopro-	NULL
Received	NULL
1/16/91	NULL
.	NULL
'	NULL

This	NULL
investigation	NULL
was	NULL
supported	NULL
by	NULL
USPHS	NULL
Grant	NULL
CA-34183	NULL
awarded	NULL
by	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
and	NULL
by	NULL
a	NULL
Burroughs	NULL
Wellcome	NULL
Award	NULL
in	NULL
Clinical	NULL
Pharmacology	NULL
(	NULL
D.	NULL
K.	NULL
)	NULL
.	NULL

2	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
M-CSF	NULL
,	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
;	NULL
TRE	NULL
,	NULL
TPA-responsive	NULL
element	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
TGF-8	NULL
,	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
;	NULL
kb	NULL
,	NULL
kilobase	NULL
(	NULL
s	NULL
)	NULL
;	NULL
cDNA	NULL
,	NULL
complementary	NULL
DNA	NULL
;	NULL
SSC	NULL
,	NULL
standard	NULL
saline	NULL
citrate	NULL
;	NULL
SDS	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
.	NULL

teins	NULL
with	NULL
intrinsic	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Ligand	NULL
binding	NULL
induces	NULL
autophosphorylation	NULL
and	NULL
down-regulation	NULL
of	NULL
the	NULL
c-fms	NULL
protein	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Multiple	NULL
other	NULL
substrates	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
have	NULL
been	NULL
detected	NULL
following	NULL
activation	NULL
of	NULL
this	NULL
receptor	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
identity	NULL
of	NULL
these	NULL
substrates	NULL
has	NULL
in	NULL
part	NULL
remained	NULL
unclear	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
M-CSF	NULL
receptor	NULL
associates	NULL
with	NULL
and	NULL
activates	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

M-CSF	NULL
also	NULL
stimulates	NULL
protein	NULL
synthesis	NULL
,	NULL
glucose	NULL
uptake	NULL
,	NULL
and	NULL
Nat	NULL
,	NULL
K*-ATPase	NULL
activity	NULL
in	NULL
macrophages	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
activated	NULL
M-CSF	NULL
receptor	NULL
stimulates	NULL
a	NULL
pertussis	NULL
toxin-sensitive	NULL
GTPase	NULL
activity	NULL
and	NULL
that	NULL
M-CSF	NULL
induces	NULL
certain	NULL
pertussis	NULL
toxin-sensitive	NULL
signaling	NULL
events	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

Otherwise	NULL
,	NULL
there	NULL
are	NULL
few	NULL
insights	NULL
regarding	NULL
pathways	NULL
activated	NULL
by	NULL
ligand	NULL
binding	NULL
to	NULL
this	NULL
receptor	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
M-CSF	NULL
stimulation	NULL
of	NULL
murine	NULL
macrophages	NULL
and	NULL
the	NULL
BAC1.2F5	NULL
macrophage	NULL
cell	NULL
line	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
rapid	NULL
and	NULL
transient	NULL
increase	NULL
in	NULL
c-fos	NULL
gene	NULL
expression	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

A	NULL
rapid	NULL
induction	NULL
of	NULL
c-fos	NULL
expression	NULL
similarly	NULL
occurs	NULL
during	NULL
phorbol	NULL
ester-induced	NULL
monocytic	NULL
differentiation	NULL
of	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
to	NULL
macrophages	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

The	NULL
c-fos	NULL
gene	NULL
encodes	NULL
a	NULL
nuclear	NULL
protein	NULL
which	NULL
participates	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
complex	NULL
(	NULL
22	NULL
)	NULL
.	NULL

A	NULL
major	NULL
component	NULL
of	NULL
this	NULL
complex	NULL
is	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-jun	NULL
protooncogene	NULL
(	NULL
22	NULL
)	NULL
.	NULL

This	NULL
gene	NULL
is	NULL
also	NULL
induced	NULL
as	NULL
an	NULL
immediate	NULL
early	NULL
response	NULL
to	NULL
certain	NULL
growth	NULL
factors	NULL
and	NULL
phorbol	NULL
esters	NULL
(	NULL
23-25	NULL
)	NULL
.	NULL

The	NULL
Jun/AP-1	NULL
complex	NULL
binds	NULL
to	NULL
a	NULL
heptomeric	NULL
DNA	NULL
consensus	NULL
sequence	NULL
TGAÂ®/.TCA	NULL
(	NULL
TRE	NULL
)	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
affinity	NULL
of	NULL
Jun/AP-1	NULL
binding	NULL
to	NULL
the	NULL
TRE	NULL
is	NULL
related	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
with	NULL
fos	NULL
proteins	NULL
(	NULL
27-29	NULL
)	NULL
.	NULL

Jun-B	NULL
is	NULL
another	NULL
member	NULL
of	NULL
the	NULL
jun	NULL
family	NULL
that	NULL
forms	NULL
dimers	NULL
and	NULL
binds	NULL
to	NULL
the	NULL
TRE	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
,	NULL
although	NULL
the	NULL
properties	NULL
of	NULL
c-Jun	NULL
and	NULL
Jun-B	NULL
differ	NULL
in	NULL
that	NULL
Jun-B	NULL
inhibits	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
activated	NULL
by	NULL
c-jun	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
M-CSF	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
either	NULL
c-jun	NULL
or	NULL
jun-B	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
have	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
M-CSF	NULL
on	NULL
c-jun	NULL
expression	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
that	NULL
M-CSF	NULL
increases	NULL
c-jun	NULL
expression	NULL
by	NULL
both	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
mechanisms	NULL
.	NULL

The	NULL
results	NULL
further	NULL
demonstrate	NULL
that	NULL
M-CSF	NULL
increases	NULL
jun-B	NULL
mRNA	NULL
levels	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Since	NULL
jun	NULL
forms	NULL
heterodimers	NULL
with	NULL
fos	NULL
proteins	NULL
,	NULL
we	NULL
have	NULL
also	NULL
studied	NULL
the	NULL
effects	NULL
of	NULL
M-CSF	NULL
on	NULL
c-fos	NULL
and	NULL
fos-related	NULL
genes	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Results	NULL
Studies	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
M-CSF	NULL
on	NULL
c-jun	NULL
expression	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

There	NULL
was	NULL
a	NULL
low	NULL
but	NULL
detectable	NULL
level	NULL
of	NULL
c-jun	NULL
transcripts	NULL
in	NULL
resting	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
with	NULL
10Â°	NULL
units/ml	NULL
M-CSF	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
c-jun	NULL
expression	NULL
that	NULL
was	NULL
detectable	NULL
268	NULL
-	NULL
M-CSF	NULL
Induces	NULL
jun	NULL
and	NULL
fos	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
Monocytes	NULL
Monocytes	NULL
F	NULL
O	NULL
(	NULL
m	NULL
2	NULL
<	NULL
9	NULL
)	NULL
m-	NULL
Â®	NULL
28S-I	NULL
.	NULL

c-jun	NULL
18s-28S-	NULL
18s-	NULL
ae	NULL
a	NULL
u	NULL
288_	NULL
44	NULL
14	NULL
&	NULL
he	NULL
&	NULL
Uf	NULL
actin	NULL
18S-	NULL
w	NULL
M-CSF	NULL
S	NULL
-	NULL
U/ml	NULL
Â»	NULL
--	NULL
--	NULL
--	NULL
--	NULL
o	NULL
o	NULL
o	NULL
0	NULL
g	NULL
-_	NULL
aw	NULL
ec	NULL
*C	NULL
0	NULL
o	NULL
0	NULL
x	NULL
2	NULL
ww	NULL
m-	NULL
0	NULL
28S-bo	NULL
tt	NULL
.	NULL

C	NULL
-jun	NULL
18S-28S-	NULL
1ss-	NULL
``	NULL
W	NULL
#	NULL
OU	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Effects	NULL
of	NULL
M-CSF	NULL
on	NULL
c-jun	NULL
and	NULL
jun-B	NULL
mRNA	NULL
levels	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

A	NULL
,	NULL
resting	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
10Â°	NULL
units/ml	NULL
M-CSF	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

8	NULL
,	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
M-CSF	NULL
concentrations	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
isolated	NULL
and	NULL
hybridized	NULL
to	NULL
``	NULL
P-labeled	NULL
c-jun	NULL
,	NULL
jun-B	NULL
,	NULL
and	NULL
actin	NULL
DNA	NULL
probes	NULL
.	NULL

Actin	NULL
signals	NULL
in	NULL
8	NULL
demonstrated	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

at	NULL
15	NULL
min	NULL
and	NULL
reached	NULL
maximal	NULL
levels	NULL
at	NULL
30	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Longer	NULL
exposures	NULL
were	NULL
associated	NULL
with	NULL
down-regulation	NULL
of	NULL
c-jun	NULL
transcripts	NULL
to	NULL
pretreatment	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

M-CSF	NULL
treatment	NULL
was	NULL
also	NULL
associated	NULL
with	NULL
expression	NULL
of	NULL
the	NULL
jun-B	NULL
gene	NULL
.	NULL

jun-B	NULL
transcripts	NULL
were	NULL
similarly	NULL
increased	NULL
by	NULL
15	NULL
min	NULL
of	NULL
M-CSF	NULL
exposure	NULL
and	NULL
remained	NULL
elevated	NULL
for	NULL
longer	NULL
periods	NULL
than	NULL
that	NULL
for	NULL
the	NULL
c-jun	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
M-CSF	NULL
on	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
were	NULL
concentration	NULL
dependent	NULL
.	NULL

Expression	NULL
of	NULL
both	NULL
the	NULL
c-jun	NULL
and	NULL
jun-B	NULL
genes	NULL
was	NULL
increased	NULL
following	NULL
exposure	NULL
to	NULL
10	NULL
units/ml	NULL
M-CSF	NULL
for	NULL
15	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
stimulation	NULL
with	NULL
higher	NULL
M-CSF	NULL
concentrations	NULL
was	NULL
associated	NULL
with	NULL
progressive	NULL
increases	NULL
in	NULL
levels	NULL
of	NULL
these	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
boiling	NULL
the	NULL
M-CSF	NULL
(	NULL
10Â°	NULL
units/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
completely	NULL
abrogated	NULL
these	NULL
effects	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
in	NULL
murine	NULL
macrophages	NULL
have	NULL
demonstrated	NULL
that	NULL
M-CSF	NULL
rapidly	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
in	NULL
the	NULL
present	NULL
studies	NULL
with	NULL
human	NULL
monocytes	NULL
.	NULL

c-fos	NULL
transcripts	NULL
were	NULL
present	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

However	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
c-fos	NULL
expression	NULL
was	NULL
detectable	NULL
by	NULL
15	NULL
min	NULL
of	NULL
M-CSF	NULL
stimulation	NULL
and	NULL
then	NULL
declined	NULL
to	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
untreated	NULL
cells	NULL
by	NULL
3	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
for	NULL
two	NULL
c-fos-related	NULL
genes	NULL
.	NULL

For	NULL
example	NULL
,	NULL
fos-B	NULL
and	NULL
fra-1	NULL
mRNA	NULL
levels	NULL
were	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
unstimulated	NULL
monocytes	NULL
.	NULL

Maximal	NULL
increases	NULL
in	NULL
fos-B	NULL
expression	NULL
were	NULL
obtained	NULL
at	NULL
30	NULL
min	NULL
,	NULL
whereas	NULL
fra-1	NULL
transcripts	NULL
reached	NULL
highest	NULL
levels	NULL
by	NULL
1	NULL
h	NULL
of	NULL
M-CSF	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
M-CSF	NULL
on	NULL
fos	NULL
gene	NULL
expression	NULL
were	NULL
also	NULL
concentration	NULL
dependent	NULL
.	NULL

Exposure	NULL
of	NULL
monocytes	NULL
to	NULL
10	NULL
units/ml	NULL
M-CSF	NULL
was	NULL
associated	NULL
with	NULL
increases	NULL
in	NULL
c-fos	NULL
transcripts	NULL
,	NULL
whereas	NULL
maximal	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
was	NULL
achieved	NULL
with	NULL
5	NULL
X	NULL
10Â°	NULL
units/ml	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
M-CSF	NULL
transiently	NULL
increases	NULL
expression	NULL
of	NULL
multiple	NULL
genes	NULL
in	NULL
the	NULL
c-jun	NULL
and	NULL
c-fos	NULL
families	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
TPA	NULL
increases	NULL
c-jun	NULL
expression	NULL
in	NULL
myeloid	NULL
cells	NULL
by	NULL
activation	NULL
of	NULL
this	NULL
gene	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Run-on	NULL
assays	NULL
were	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
M-CSF	NULL
similarly	NULL
induces	NULL
transcription	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
monocytes	NULL
.	NULL

Nuclear	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
monocytes	NULL
treated	NULL
with	NULL
10Â°	NULL
units/	NULL
ml	NULL
M-CSF	NULL
for	NULL
15	NULL
min	NULL
and	NULL
hybridized	NULL
to	NULL
actin	NULL
and	NULL
c-jun	NULL
DNAs	NULL
.	NULL

The	NULL
actin	NULL
gene	NULL
was	NULL
transcriptionally	NULL
active	NULL
in	NULL
resting	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
effect	NULL
of	NULL
M-CSF	NULL
on	NULL
transcription	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

Low	NULL
but	NULL
detectable	NULL
levels	NULL
of	NULL
c-jun	NULL
gene	NULL
transcription	NULL
were	NULL
found	NULL
in	NULL
untreated	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
M-CSF	NULL
stimulation	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
2.9-fold	NULL
(	NULL
deter-mined	NULL
by	NULL
densitometric	NULL
scanning	NULL
)	NULL
increase	NULL
in	NULL
the	NULL
c-jun	NULL
transcriptional	NULL
rate	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
for	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
c-fos	NULL
gene	NULL
transcription	NULL
was	NULL
increased	NULL
2.0-fold	NULL
following	NULL
M-CSF	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
c-jun	NULL
gene	NULL
is	NULL
also	NULL
regulated	NULL
by	NULL
posttranscriptional	NULL
mechanisms	NULL
during	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
c-jun	NULL
transcript	NULL
in	NULL
resting	NULL
and	NULL
M-CSF-stimulated	NULL
monocytes	NULL
.	NULL

Resting	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
actinomycin	NULL
D	NULL
to	NULL
inhibit	NULL
transcription	NULL
and	NULL
then	NULL
monitored	NULL
for	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
.	NULL

The	NULL
half-life	NULL
of	NULL
c-jun	NULL
mRNA	NULL
in	NULL
these	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
densitometric	NULL
scanning	NULL
was	NULL
17	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
the	NULL
monocytes	NULL
with	NULL
M-CSF	NULL
for	NULL
15	NULL
min	NULL
and	NULL
then	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
prolongation	NULL
of	NULL
the	NULL
half-life	NULL
to	NULL
27	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
comparable	NULL
to	NULL
those	NULL
obtained	NULL
for	NULL
the	NULL
c-fos	NULL
transcript	NULL
.	NULL

The	NULL
half-life	NULL
of	NULL
c-fos	NULL
mRNA	NULL
in	NULL
resting	NULL
monocytes	NULL
was	NULL
13	NULL
min	NULL
,	NULL
whereas	NULL
M-CSF	NULL
treatment	NULL
was	NULL
associated	NULL
with	NULL
an	NULL
increase	NULL
to	NULL
25	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
M-CSF	NULL
regulates	NULL
expression	NULL
of	NULL
the	NULL
c-jun	NULL
and	NULL
c-fos	NULL
genes	NULL
by	NULL
both	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
mechanisms	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
A	NULL
Â®	NULL
O	NULL
pal	NULL
o	NULL
M-CSF	NULL
am	NULL
-_-0	NULL
m	NULL
1	NULL
Â£	NULL
â¬	NULL
28Â§S-	NULL
_	NULL
__	NULL
db	NULL
c-fos	NULL
18S-28S-	NULL
18s-28S-	NULL
18S-	NULL
a4	NULL
B	NULL
w	NULL
M-CSF	NULL
pus	NULL
U/ml	NULL
Bm	NULL
--	NULL
-I	NULL
O	NULL
&	NULL
le	NULL
]	NULL
O	NULL
g	NULL
--	NULL
A	NULL
&	NULL
2	NULL
:	NULL
s	NULL
2	NULL
2Â°	NULL
2	NULL
B	NULL
28S-c-fos	NULL
18S-28S5-	NULL
W	NULL
W	NULL
m	NULL
,	NULL
actin	NULL
18s-	NULL
@	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effects	NULL
of	NULL
M-CSF	NULL
on	NULL
c-fos	NULL
,	NULL
fos-B	NULL
,	NULL
and	NULL
fra-1	NULL
mRNA	NULL
levels	NULL
in	NULL
monocytes	NULL
.	NULL

A	NULL
,	NULL
resting	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
10Â°	NULL
units/ml	NULL
M-CSF	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

8	NULL
,	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
M-CSF	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
P-labeled	NULL
DNA	NULL
probes	NULL
.	NULL

Actin	NULL
signals	NULL
in	NULL
A	NULL
demonstrated	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
are	NULL
terminally	NULL
differentiated	NULL
and	NULL
fail	NULL
to	NULL
exit	NULL
G	NULL
,	NULL
-Gi	NULL
phase	NULL
in	NULL
response	NULL
to	NULL
activating	NULL
signals	NULL
(	NULL
34	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
treatment	NULL
with	NULL
M-CSF	NULL
under	NULL
the	NULL
present	NULL
experimental	NULL
conditions	NULL
was	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
a	NULL
more	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
,	NULL
we	NULL
studied	NULL
expression	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
,	NULL
a	NULL
marker	NULL
of	NULL
monocyte	NULL
activation	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

TNF	NULL
transcripts	NULL
were	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
unstimulated	NULL
monocytes	NULL
,	NULL
c	NULL
9	NULL
c	NULL
Â®	NULL
c	NULL
o	NULL
Â£	NULL
3	NULL
o	NULL
â¬	NULL
3	NULL
o	NULL
Â£	NULL
3	NULL
o	NULL
4+	NULL
Â»	NULL
=~	NULL
ye	NULL
4-4	NULL
an	NULL
e	NULL
#	NULL
4	NULL
(	NULL
ge	NULL
o	NULL
I	NULL
I	NULL
0	NULL
I	NULL
1	NULL
8	NULL
(	NULL
l	NULL
)	NULL
I	NULL
Kb	NULL
Â®	NULL
o	NULL
o	NULL
it	NULL
;	NULL
0	NULL
o	NULL
-	NULL
el	NULL
4.3	NULL
|	NULL
--	NULL
.	NULL

2.0	NULL
--	NULL
___	NULL
Control	NULL
M-CSF	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Analysis	NULL
of	NULL
gene	NULL
transcription	NULL
in	NULL
resting	NULL
and	NULL
M-CSF	NULL
-treated	NULL
mono	NULL
cytes	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
with	NULL
10Â°	NULL
units/ml	NULL
M-CSF	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
newly	NULL
elongated	NULL
``	NULL
P-labeled	NULL
RNA	NULL
transcripts	NULL
were	NULL
hybridized	NULL
to	NULL
2	NULL
ug	NULL
of	NULL
actin	NULL
,	NULL
c-jun	NULL
,	NULL
or	NULL
c-fos	NULL
DNA	NULL
insert	NULL
after	NULL
restriction	NULL
enzyme	NULL
digestion	NULL
and	NULL
Southern	NULL
blotting	NULL
.	NULL

As	NULL
compared	NULL
to	NULL
that	NULL
for	NULL
the	NULL
actin	NULL
gene	NULL
,	NULL
c-jun	NULL
gene	NULL
transcription	NULL
was	NULL
increased	NULL
2.9-fold	NULL
and	NULL
c-fos	NULL
gene	NULL
transcription	NULL
by	NULL
2.0-fold	NULL
following	NULL
M-CSF	NULL
stimulation	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
for	NULL
the	NULL
c-jun	NULL
gene	NULL
(	NULL
2.9-	NULL
and	NULL
1.9-fold	NULL
increases	NULL
)	NULL
and	NULL
the	NULL
cfos	NULL
gene	NULL
(	NULL
2.0-	NULL
and	NULL
1.5-fold	NULL
increases	NULL
)	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

In	NULL
the	NULL
schematic	NULL
diagram	NULL
,	NULL
solid	NULL
lines	NULL
,	NULL
positions	NULL
of	NULL
the	NULL
DNA	NULL
inserts	NULL
;	NULL
dashed	NULL
lines	NULL
,	NULL
positions	NULL
of	NULL
the	NULL
plasmid	NULL
vectors	NULL
.	NULL

whereas	NULL
treatment	NULL
with	NULL
M-CSF	NULL
was	NULL
associated	NULL
with	NULL
increases	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
of	NULL
M-CSF	NULL
was	NULL
maximal	NULL
at	NULL
1	NULL
h	NULL
and	NULL
then	NULL
followed	NULL
by	NULL
down-regulation	NULL
of	NULL
these	NULL
transcripts	NULL
to	NULL
near	NULL
baseline	NULL
levels	NULL
at	NULL
6	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
TGF-B	NULL
gene	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
resting	NULL
monocytes	NULL
,	NULL
and	NULL
there	NULL
was	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
effect	NULL
of	NULL
M-CSF	NULL
on	NULL
levels	NULL
of	NULL
these	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
effect	NULL
of	NULL
M-CSF	NULL
on	NULL
c-myc	NULL
or	NULL
c-myb	NULL
mRNA	NULL
levels	NULL
in	NULL
the	NULL
M-CSF-stimulated	NULL
monocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
induction	NULL
of	NULL
jun/fos	NULL
gene	NULL
expression	NULL
by	NULL
M-CSF	NULL
is	NULL
associated	NULL
with	NULL
activation	NULL
to	NULL
a	NULL
more	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
.	NULL

Discussion	NULL
The	NULL
present	NULL
studies	NULL
demonstrate	NULL
that	NULL
activation	NULL
of	NULL
resting	NULL
human	NULL
monocytes	NULL
with	NULL
M-CSF	NULL
is	NULL
associated	NULL
with	NULL
rapid	NULL
and	NULL
transient	NULL
increases	NULL
in	NULL
expression	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
.	NULL

Nuclear	NULL
run-on	NULL
assays	NULL
and	NULL
mRNA	NULL
stability	NULL
studies	NULL
indicate	NULL
that	NULL
this	NULL
effect	NULL
of	NULL
M-CSF	NULL
on	NULL
c-jun	NULL
expression	NULL
is	NULL
controlled	NULL
at	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
levels	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
is	NULL
an	NULL
early	NULL
event	NULL
during	NULL
stimulation	NULL
of	NULL
fibroblasts	NULL
.	NULL

For	NULL
example	NULL
,	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
are	NULL
transcriptionally	NULL
and	NULL
posttranscriptionally	NULL
regulated	NULL
by	NULL
serum	NULL
,	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
,	NULL
and	NULL
fibroblast	NULL
growth	NULL
factor	NULL
in	NULL
mouse	NULL
BALB/c	NULL
3T3	NULL
cells	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Other	NULL
work	NULL
in	NULL
myeloid	NULL
cells	NULL
has	NULL
demonstrated	NULL
that	NULL
the	NULL
c-jun	NULL
gene	NULL
is	NULL
expressed	NULL
during	NULL
TPA-induced	NULL
monocytic	NULL
differentiation	NULL
and	NULL
monocyte	NULL
activation	NULL
by	NULL
lipopolysaccharide	NULL
(	NULL
33	NULL
,	NULL
38	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
similarly	NULL
demonstrated	NULL
increases	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
c-jun	NULL
transcription	NULL
and	NULL
a	NULL
prolongation	NULL
in	NULL
the	NULL
half-life	NULL
of	NULL
the	NULL
c-jun	NULL
transcript	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
present	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
in	NULL
M-CSF-treated	NULL
monocytes	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
other	NULL
models	NULL
of	NULL
monocytic	NULL
differentiation	NULL
or	NULL
activation	NULL
.	NULL

Although	NULL
lipopolysaccharide	NULL
can	NULL
also	NULL
increase	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
(	NULL
38	NULL
)	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
contaminating	NULL
endotoxin	NULL
in	NULL
the	NULL
M-CSF	NULL
preparation	NULL
contributed	NULL
to	NULL
the	NULL
present	NULL
findings	NULL
is	NULL
unlikely	NULL
.	NULL

in	NULL
this	NULL
context	NULL
,	NULL
boiling	NULL
the	NULL
M-CSF	NULL
completely	NULL
abolished	NULL
induction	NULL
of	NULL
c-jun	NULL
expression	NULL
.	NULL

269	NULL
270	NULL
-	NULL
M-CSF	NULL
Induces	NULL
jun	NULL
and	NULL
fos	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
Monocytes	NULL
A	NULL
B	NULL
&	NULL
2	NULL
3	NULL
-	NULL
act	NULL
D	NULL
w-	NULL
act	NULL
D	NULL
eM	NULL
OIT	NULL
D	NULL
8	NULL
$	NULL
Â°	NULL
g	NULL
1	NULL
o	NULL
Â£	NULL
}	NULL
g	NULL
f	NULL
28S-	NULL
-	NULL
e	NULL
â	NULL
a	NULL
c-jun	NULL
18S-	NULL
-	NULL
*	NULL
v=	NULL
28S-	NULL
-	NULL
,	NULL
ge	NULL
i	NULL
c-fos	NULL
18s-	NULL
W	NULL
~	NULL
-	NULL
h	NULL
â	NULL
Tig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Stability	NULL
of	NULL
the	NULL
c-jun	NULL
and	NULL
c-fos	NULL
transcripts	NULL
in	NULL
resting	NULL
and	NULL
M-CSF-treated	NULL
monocytes	NULL
.	NULL

Resting	NULL
monocytes	NULL
(	NULL
A	NULL
)	NULL
and	NULL
monocytes	NULL
stimulated	NULL
with	NULL
10Â°	NULL
units/ml	NULL
M-CSF	NULL
for	NULL
15	NULL
min	NULL
(	NULL
B	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
5	NULL
ug/ml	NULL
actinomycin	NULL
D	NULL
(	NULL
act	NULL
1	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
g	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
``	NULL
P-labeled	NULL
c-jun	NULL
and	NULL
c-fos	NULL
DNA	NULL
probes	NULL
.	NULL

Filters	NULL
prepared	NULL
with	NULL
RNA	NULL
from	NULL
resting	NULL
monocytes	NULL
were	NULL
overexposed	NULL
to	NULL
visualize	NULL
the	NULL
signals	NULL
.	NULL

Hybridization	NULL
to	NULL
the	NULL
actin	NULL
probe	NULL
revealed	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

Similar	NULL
findings	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
c-jun	NULL
gene	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
multigene	NULL
family	NULL
coding	NULL
for	NULL
products	NULL
that	NULL
contain	NULL
a	NULL
leucine	NULL
zipper	NULL
motif	NULL
and	NULL
a	NULL
highly	NULL
conserved	NULL
DNA-binding	NULL
domain	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
leucine	NULL
zipper	NULL
allows	NULL
for	NULL
dimerization	NULL
between	NULL
certain	NULL
members	NULL
of	NULL
this	NULL
family	NULL
,	NULL
whereas	NULL
the	NULL
basic	NULL
domain	NULL
binds	NULL
to	NULL
TRE	NULL
.	NULL

Specific	NULL
protein	NULL
dimeric	NULL
complexes	NULL
contribute	NULL
to	NULL
the	NULL
affinity	NULL
and	NULL
specificity	NULL
of	NULL
DNA	NULL
binding	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
c-jun	NULL
and	NULL
c-fos	NULL
form	NULL
complexes	NULL
with	NULL
a	NULL
higher	NULL
DNA-binding	NULL
affinity	NULL
than	NULL
that	NULL
of	NULL
c-jun	NULL
homodimers	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
M-CSF	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
c-jun	NULL
and	NULL
c-fos	NULL
genes	NULL
suggests	NULL
that	NULL
both	NULL
Jun/Jun	NULL
and	NULL
Jun/Fos	NULL
complexes	NULL
can	NULL
be	NULL
formed	NULL
in	NULL
activated	NULL
monocytes	NULL
.	NULL

The	NULL
basis	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
different	NULL
complexes	NULL
may	NULL
be	NULL
determined	NULL
by	NULL
the	NULL
timing	NULL
and	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
response	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
maximal	NULL
induction	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
at	NULL
30	NULL
min	NULL
of	NULL
M-CSF	NULL
stimulation	NULL
occurred	NULL
during	NULL
down-regulation	NULL
of	NULL
c-fos	NULL
transcripts	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
that	NULL
this	NULL
rapid	NULL
induction	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
by	NULL
M-CSF	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
levels	NULL
.	NULL

Similar	NULL
control	NULL
of	NULL
c-fos	NULL
expression	NULL
has	NULL
been	NULL
obtained	NULL
in	NULL
TPA-treated	NULL
human	NULL
monocytes	NULL
(	NULL
40	NULL
)	NULL
.	NULL

M-CSF	NULL
-	NULL
or	NULL
TPA-induced	NULL
increases	NULL
in	NULL
the	NULL
c-fos	NULL
product	NULL
may	NULL
contribute	NULL
to	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
through	NULL
the	NULL
formation	NULL
of	NULL
AP-1	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
TRE	NULL
in	NULL
the	NULL
c-jun	NULL
promoter	NULL
.	NULL

The	NULL
present	NULL
findings	NULL
also	NULL
demonstrate	NULL
that	NULL
M-CSF	NULL
treatment	NULL
is	NULL
associated	NULL
with	NULL
increases	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
other	NULL
members	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
family	NULL
.	NULL

M-CSF-induced	NULL
jun-B	NULL
gene	NULL
expression	NULL
was	NULL
more	NULL
prolonged	NULL
than	NULL
that	NULL
for	NULL
the	NULL
c-jun	NULL
gene	NULL
.	NULL

Jun-B	NULL
functions	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
genes	NULL
activated	NULL
by	NULL
c-Jun	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
and	NULL
thereby	NULL
could	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
down-regulation	NULL
of	NULL
c-jun	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
expression	NULL
of	NULL
the	NULL
jun-D	NULL
gene	NULL
(	NULL
41	NULL
)	NULL
in	NULL
resting	NULL
or	NULL
M-CSF-treated	NULL
monocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
in	NULL
studies	NULL
with	NULL
fibroblasts	NULL
,	NULL
the	NULL
jun-D	NULL
gene	NULL
is	NULL
regulated	NULL
differently	NULL
than	NULL
c-jun	NULL
and	NULL
jun-B	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
role	NULL
of	NULL
Jun-D	NULL
is	NULL
unknown	NULL
,	NULL
although	NULL
this	NULL
protein	NULL
M-CSF	NULL
--	NULL
-I	NULL
]	NULL
``	NULL
OE-CC	NULL
Â®	NULL
~	NULL
Â®	NULL
Â©	NULL
Monocytes	NULL
28S-	NULL
*e	NULL
...	NULL
TNF	NULL
18S-	NULL
28S-	NULL
U	NULL
WU	NULL
W	NULL
{	NULL
35	NULL
Â®	NULL
Â®	NULL
a	NULL
t	NULL
Â®	NULL
TGF-8	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
M-CSF	NULL
on	NULL
TNF	NULL
and	NULL
TGF-8	NULL
gene	NULL
expression	NULL
.	NULL

Resting	NULL
monocytes	NULL
were	NULL
treated	NULL
with	NULL
10Â°	NULL
units/ml	NULL
M-CSF	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
P-labeled	NULL
TNF	NULL
and	NULL
TGF-d	NULL
probes	NULL
.	NULL

also	NULL
interacts	NULL
with	NULL
c-Fos	NULL
and	NULL
has	NULL
similar	NULL
binding	NULL
properties	NULL
to	NULL
that	NULL
of	NULL
c-Jun	NULL
(	NULL
42	NULL
)	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
also	NULL
demonstrate	NULL
that	NULL
M-CSF	NULL
increases	NULL
expression	NULL
of	NULL
the	NULL
fos-B	NULL
(	NULL
27	NULL
)	NULL
and	NULL
fra-	NULL
1	NULL
(	NULL
43	NULL
)	NULL
genes	NULL
.	NULL

The	NULL
Fos-B	NULL
protein	NULL
influences	NULL
binding	NULL
of	NULL
c-Jun	NULL
and	NULL
Jun-B	NULL
(	NULL
27	NULL
)	NULL
,	NULL
whereas	NULL
Fra-1	NULL
affects	NULL
binding	NULL
of	NULL
c-jun	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
fos-B	NULL
expression	NULL
following	NULL
M-CSF	NULL
stimulation	NULL
was	NULL
delayed	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
c-fos	NULL
.	NULL

Furthermore	NULL
,	NULL
M-CSF-induced	NULL
fra-1	NULL
transcripts	NULL
were	NULL
detectable	NULL
after	NULL
maximal	NULL
expression	NULL
of	NULL
both	NULL
the	NULL
c-fos	NULL
and	NULL
fos-B	NULL
genes	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
fra-1	NULL
gene	NULL
in	NULL
serum-stimulated	NULL
fibroblasts	NULL
is	NULL
also	NULL
delayed	NULL
in	NULL
comparison	NULL
to	NULL
c-fos	NULL
expression	NULL
(	NULL
43	NULL
)	NULL
.	NULL

This	NULL
differential	NULL
activation	NULL
of	NULL
multiple	NULL
members	NULL
of	NULL
the	NULL
jun/fos	NULL
family	NULL
could	NULL
result	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
diverse	NULL
leucine	NULL
zipper	NULL
dimers	NULL
that	NULL
regulate	NULL
a	NULL
specific	NULL
program	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
present	NULL
findings	NULL
thus	NULL
suggest	NULL
that	NULL
one	NULL
of	NULL
the	NULL
earliest	NULL
genomic	NULL
responses	NULL
to	NULL
M-CSF	NULL
involves	NULL
nuclear	NULL
signal	NULL
transduction	NULL
through	NULL
activation	NULL
of	NULL
jun/fos	NULL
genes	NULL
.	NULL

The	NULL
M-CSF-induced	NULL
cytoplasmic	NULL
signals	NULL
that	NULL
contribute	NULL
to	NULL
these	NULL
effects	NULL
are	NULL
unclear	NULL
.	NULL

The	NULL
activated	NULL
M-CSF	NULL
receptor	NULL
phosphorylates	NULL
a	NULL
variety	NULL
of	NULL
substrates	NULL
on	NULL
tyrosine	NULL
and	NULL
is	NULL
associated	NULL
with	NULL
phosphatidylinositol	NULL
3-kinase	NULL
activity	NULL
(	NULL
5-9	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
M-CSF	NULL
activates	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
resting	NULL
monocytes	NULL
with	NULL
TPA	NULL
,	NULL
an	NULL
activator	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
is	NULL
similarly	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
c-jun	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
c-fos	NULL
(	NULL
40	NULL
)	NULL
gene	NULL
expression	NULL
.	NULL

TPA	NULL
also	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
TNF	NULL
and	NULL
other	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
,	NULL
that	NULL
characterize	NULL
the	NULL
more	NULL
differentiated	NULL
monocytic	NULL
phenotype	NULL
(	NULL
36	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
monocyte	NULL
activation	NULL
is	NULL
unknown	NULL
,	NULL
the	NULL
present	NULL
findings	NULL
with	NULL
M-CSF	NULL
and	NULL
previous	NULL
studies	NULL
with	NULL
TPA	NULL
indicate	NULL
that	NULL
jun/fos	NULL
gene	NULL
expression	NULL
may	NULL
represent	NULL
nuclear	NULL
signaling	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Materials	NULL
and	NULL
Methods	NULL
Monocyte	NULL
Purification	NULL
and	NULL
Culture	NULL
.	NULL

Human	NULL
monocytes	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
adherence	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
adherent	NULL
cell	NULL
population	NULL
was	NULL
collected	NULL
with	NULL
a	NULL
plastic	NULL
policeman	NULL
,	NULL
washed	NULL
with	NULL
three	NULL
changes	NULL
of	NULL
medium	NULL
,	NULL
readhered	NULL
,	NULL
and	NULL
then	NULL
washed	NULL
again	NULL
with	NULL
medium	NULL
.	NULL

The	NULL
purified	NULL
cell	NULL
population	NULL
consisted	NULL
of	NULL
over	NULL
95	NULL
%	NULL
monocytes	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
morphological	NULL
examination	NULL
and	NULL
a-naphthyl	NULL
acetate	NULL
esterase	NULL
staining	NULL
.	NULL

Monocyte	NULL
purification	NULL
and	NULL
culturing	NULL
were	NULL
performed	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
4	NULL
mm	NULL
glutamine	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
.	NULL

Isolation	NULL
and	NULL
Analysis	NULL
of	NULL
Monocyte	NULL
RNA	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
purified	NULL
by	NULL
the	NULL
guanidine	NULL
isothiocyanate-ce-sium	NULL
chloride	NULL
technique	NULL
(	NULL
46	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
through	NULL
1	NULL
%	NULL
agarose-formaldehyde	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
following	NULL
*Â°P-labeled	NULL
DNA	NULL
probes	NULL
:	NULL
(	NULL
a	NULL
)	NULL
the	NULL
1.8-kb	NULL
BamHI/	NULL
EcoRI	NULL
insert	NULL
of	NULL
a	NULL
human	NULL
c-jun	NULL
gene	NULL
purified	NULL
from	NULL
a	NULL
pBluescript	NULL
SK	NULL
(	NULL
+	NULL
)	NULL
plasmid	NULL
(	NULL
47	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
the	NULL
1.5-kb	NULL
EcoRI	NULL
fragment	NULL
of	NULL
the	NULL
murine	NULL
jun-B	NULL
cDNA	NULL
from	NULL
the	NULL
p465.20	NULL
plasmid	NULL
(	NULL
30	NULL
)	NULL
;	NULL
(	NULL
c	NULL
)	NULL
the	NULL
0.9-kb	NULL
Scal/Ncot	NULL
insert	NULL
of	NULL
a	NULL
human	NULL
c-fos	NULL
gene	NULL
purified	NULL
from	NULL
the	NULL
pce-fos-1	NULL
plasmid	NULL
(	NULL
48	NULL
)	NULL
;	NULL
(	NULL
d	NULL
)	NULL
the	NULL
2-kb	NULL
EcoRl	NULL
insert	NULL
of	NULL
a	NULL
mouse	NULL
fos-B	NULL
gene	NULL
in	NULL
the	NULL
pUC19	NULL
plasmid	NULL
(	NULL
27	NULL
)	NULL
;	NULL
(	NULL
e	NULL
)	NULL
the	NULL
1.5-kb	NULL
EcoRt	NULL
insert	NULL
of	NULL
a	NULL
fra-1	NULL
gene	NULL
in	NULL
the	NULL
pSP65-fra-1	NULL
plasmid	NULL
(	NULL
43	NULL
)	NULL
;	NULL
(	NULL
f	NULL
)	NULL
the	NULL
2.0-kb	NULL
Pstl	NULL
insert	NULL
of	NULL
a	NULL
chicken	NULL
B-actin	NULL
gene	NULL
purified	NULL
from	NULL
the	NULL
pA1	NULL
plasmid	NULL
(	NULL
49	NULL
)	NULL
;	NULL
(	NULL
g	NULL
)	NULL
the	NULL
1.9-kb	NULL
BamHI/Pst	NULL
!	NULL

insert	NULL
of	NULL
a	NULL
human	NULL
TNF	NULL
cDNA	NULL
purified	NULL
from	NULL
the	NULL
pE4	NULL
plasmid	NULL
(	NULL
50	NULL
)	NULL
;	NULL
and	NULL
(	NULL
h	NULL
)	NULL
the	NULL
1.0-kb	NULL
EcoRI	NULL
fragment	NULL
of	NULL
a	NULL
human	NULL
TGF-8	NULL
cDNA	NULL
purified	NULL
from	NULL
the	NULL
pBAS	NULL
plasmid	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Hybridizations	NULL
were	NULL
performed	NULL
at	NULL
42Â°C	NULL
for	NULL
24	NULL
h	NULL
in	NULL
50	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
formamide	NULL
,	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
1x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
200	NULL
ug/ml	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
2	NULL
%	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
in	NULL
0.1	NULL
%	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
at	NULL
60Â°C	NULL
for	NULL
1	NULL
h.	NULL
Nuclear	NULL
Run-on	NULL
Assays	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
10Â°	NULL
monocytes	NULL
and	NULL
suspended	NULL
in	NULL
100	NULL
ul	NULL
glycerol	NULL
buffer	NULL
(	NULL
50	NULL
mm	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
;	NULL
,	NULL
and	NULL
0.1	NULL
mm	NULL
EDTA	NULL
)	NULL
.	NULL

An	NULL
equal	NULL
volume	NULL
of	NULL
reaction	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
5	NULL
mm	NULL
MgCli	NULL
;	NULL
,	NULL
100	NULL
mm	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
ATP	NULL
,	NULL
1	NULL
mm	NULL
CTP	NULL
,	NULL
1	NULL
mm	NULL
GTP	NULL
,	NULL
and	NULL
5	NULL
mm	NULL
dithiothreitol	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
nuclei	NULL
in	NULL
suspension	NULL
and	NULL
incubated	NULL
at	NULL
26Â°C	NULL
for	NULL
30	NULL
min	NULL
with	NULL
250	NULL
{	NULL
a-P	NULL
]	NULL
UTP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
Dupont	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
RNA	NULL
was	NULL
isolated	NULL
as	NULL
described	NULL
(	NULL
33	NULL
)	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
following	NULL
DNAs	NULL
:	NULL
(	NULL
a	NULL
)	NULL
a	NULL
Pstl	NULL
digest	NULL
of	NULL
the	NULL
pA1	NULL
plasmid	NULL
containing	NULL
a	NULL
fragment	NULL
of	NULL
the	NULL
chicken	NULL
B-actin	NULL
gene	NULL
(	NULL
49	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
a	NULL
BamHI/EcoRI	NULL
digest	NULL
of	NULL
the	NULL
pBluescript	NULL
SK	NULL
(	NULL
+	NULL
)	NULL
plasmid	NULL
containing	NULL
a	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
c-jun	NULL
gene	NULL
(	NULL
47	NULL
)	NULL
;	NULL
and	NULL
(	NULL
c	NULL
)	NULL
a	NULL
Scal/Ncol	NULL
digest	NULL
of	NULL
the	NULL
pce-fos-1	NULL
plasmid	NULL
(	NULL
48	NULL
)	NULL
.	NULL

The	NULL
digested	NULL
DNAs	NULL
were	NULL
run	NULL
in	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

Hybridizations	NULL
were	NULL
performed	NULL
with	NULL
10	NULL
``	NULL
cpm	NULL
of	NULL
P-labeled	NULL
RNA/m	NULL
!	NULL

in	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
4x	NULL
SSC	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
2x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
40	NULL
%	NULL
formamide	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
yeast	NULL
tRNA	NULL
for	NULL
72	NULL
h	NULL
at	NULL
42Â°C	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
in	NULL
:	NULL
(	NULL
a	NULL
)	NULL
2x	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
at	NULL
37Â°C	NULL
for	NULL
30	NULL
min	NULL
;	NULL
(	NULL
b	NULL
)	NULL
200	NULL
ng/ml	NULL
RNase	NULL
A	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
;	NULL
and	NULL
(	NULL
c	NULL
)	NULL
0.1	NULL
%	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
at	NULL
42Â°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
by	NULL
exposure	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
XAR	NULL
film	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Marc	NULL
Garnick	NULL
(	NULL
Genetics	NULL
Institute	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
human	NULL
recombinant	NULL
M-CSF	NULL
and	NULL
Dr.	NULL
Donna	NULL
Cohen	NULL
for	NULL
the	NULL
fra-1	NULL
probe	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Stanley	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Guilbert	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Tushinski	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Bartelemez	NULL
,	NULL
S.	NULL
H.	NULL
CSF-1	NULL
:	NULL
a	NULL
mononuclear	NULL
phagocyte	NULL
lineage-specific	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
21	NULL
:	NULL
151-159	NULL
,	NULL
1983	NULL
.	NULL

2	NULL
.	NULL

Sherr	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Rettenmier	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Sacca	NULL
,	NULL
R.	NULL
,	NULL
Roussel	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Look	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
and	NULL
Stanley	NULL
,	NULL
E.	NULL
R.	NULL
The	NULL
c-fms	NULL
proto-oncogene	NULL
product	NULL
is	NULL
related	NULL
to	NULL
the	NULL
receptor	NULL
for	NULL
the	NULL
mononuclear	NULL
phagocyte	NULL
growth	NULL
factor	NULL
,	NULL
CSF-1	NULL
.	NULL

Cell	NULL
,	NULL
41	NULL
:	NULL
665-676	NULL
,	NULL
1985	NULL
.	NULL

3	NULL
.	NULL

Yarden	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Ullrich	NULL
,	NULL
A.	NULL
Molecular	NULL
analysis	NULL
of	NULL
signal	NULL
transduction	NULL
by	NULL
growth	NULL
factors	NULL
.	NULL

Biochemistry	NULL
,	NULL
27	NULL
:	NULL
3113-3119	NULL
,	NULL
1988	NULL
.	NULL

4	NULL
.	NULL

Guilbert	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Stanley	NULL
,	NULL
E.	NULL
R.	NULL
The	NULL
interaction	NULL
of	NULL
``	NULL
*	NULL
``	NULL
l-colony-stimu-lating	NULL
factor-1	NULL
with	NULL
bone	NULL
marrow-derived	NULL
macrophages	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
261	NULL
:	NULL
4024-4032	NULL
,	NULL
1986	NULL
.	NULL

5	NULL
.	NULL

Sengupta	NULL
,	NULL
A.	NULL
,	NULL
Liu	NULL
,	NULL
W-K.	NULL
,	NULL
Yeung	NULL
,	NULL
Y.	NULL
G.	NULL
,	NULL
Yeung	NULL
,	NULL
D.	NULL
C.	NULL
Y.	NULL
,	NULL
Frackelton	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Stanley	NULL
,	NULL
E.	NULL
R.	NULL
Identification	NULL
and	NULL
subcellular	NULL
localization	NULL
of	NULL
proteins	NULL
that	NULL
are	NULL
rapidly	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
in	NULL
response	NULL
to	NULL
colony-stimulating	NULL
factor	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
8062-8066	NULL
,	NULL
1988	NULL
.	NULL

6	NULL
.	NULL

Morrison	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
Browning	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
White	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Roberts	NULL
,	NULL
T.	NULL
M.	NULL
Tyrosine	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
associated	NULL
with	NULL
v-fms	NULL
transformation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
176-185	NULL
,	NULL
1988	NULL
.	NULL

7	NULL
.	NULL

Downing	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Rettenmier	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Sherr	NULL
,	NULL
C.	NULL
J.	NULL
Ligand-induced	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
of	NULL
the	NULL
colony-stimulating	NULL
factor	NULL
1	NULL
receptor	NULL
in	NULL
a	NULL
murine	NULL
macrophage	NULL
cell	NULL
line	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
1795-1799	NULL
,	NULL
1988	NULL
.	NULL

8	NULL
.	NULL

Varticovski	NULL
,	NULL
L.	NULL
,	NULL
Druker	NULL
,	NULL
B.	NULL
,	NULL
Morrison	NULL
,	NULL
D.	NULL
,	NULL
Cantley	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Roberts	NULL
,	NULL
T.	NULL
The	NULL
colony	NULL
stimulating	NULL
factor-1	NULL
receptor	NULL
associates	NULL
with	NULL
and	NULL
activates	NULL
phosphatidylinositol-3	NULL
kinase	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
342	NULL
:	NULL
699-702	NULL
,	NULL
1909	NULL
.	NULL

9	NULL
.	NULL

Shurtleff	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Downing	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Rock	NULL
,	NULL
C.	NULL
O.	NULL
,	NULL
Hawkins	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Roussel	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Sherr	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

Structural	NULL
features	NULL
of	NULL
the	NULL
colony-stimulating	NULL
factor	NULL
1	NULL
receptor	NULL
that	NULL
affect	NULL
its	NULL
association	NULL
with	NULL
phosphatidylinositol	NULL
3-kinase	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
:	NULL
2415-2421	NULL
,	NULL
1990	NULL
.	NULL

10	NULL
.	NULL

Tushinski	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Stanley	NULL
,	NULL
E.	NULL
R.	NULL
The	NULL
regulation	NULL
of	NULL
macrophage	NULL
protein	NULL
turnover	NULL
by	NULL
a	NULL
colony	NULL
stimulating	NULL
factor	NULL
(	NULL
CSF-1	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
116	NULL
:	NULL
67-75	NULL
,	NULL
1983	NULL
.	NULL

11	NULL
.	NULL

Hamilton	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Vairo	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Lingelbach	NULL
,	NULL
S.	NULL
R.	NULL
Activation	NULL
and	NULL
proliferation	NULL
signals	NULL
in	NULL
murine	NULL
macrophages	NULL
:	NULL
stimulation	NULL
of	NULL
glucose	NULL
uptake	NULL
by	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
and	NULL
other	NULL
agents	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
134	NULL
:	NULL
405-412	NULL
,	NULL
1988	NULL
.	NULL

12	NULL
.	NULL

Vairo	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Hamilton	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Activation	NULL
and	NULL
proliferation	NULL
signals	NULL
in	NULL
murine	NULL
macrophages	NULL
:	NULL
stimulation	NULL
of	NULL
Na*	NULL
,	NULL
K*-ATPase	NULL
activity	NULL
by	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
and	NULL
other	NULL
agents	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
134	NULL
:	NULL
13-24	NULL
,	NULL
1988	NULL
.	NULL

13	NULL
.	NULL

Imamura	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Colony-stimulating	NULL
factor	NULL
1-induced	NULL
Na+	NULL
influx	NULL
into	NULL
human	NULL
monocytes	NULL
involves	NULL
activation	NULL
of	NULL
a	NULL
pertussis	NULL
toxin-sensitive	NULL
GTP-binding	NULL
protein	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
263	NULL
:	NULL
14093-14098	NULL
,	NULL
1988	NULL
.	NULL

14	NULL
.	NULL

Hartmann	NULL
,	NULL
T.	NULL
,	NULL
Seuwen	NULL
,	NULL
K.	NULL
,	NULL
Roussel	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Sherr	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Pouysse-gur	NULL
,	NULL
J.	NULL
Functional	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
receptor	NULL
for	NULL
colony-stimulating	NULL
factor	NULL
1	NULL
(	NULL
CSF-1	NULL
)	NULL
in	NULL
hamster	NULL
fibroblasts	NULL
:	NULL
CSF-1	NULL
stimulates	NULL
Na*/H*	NULL
exchange	NULL
and	NULL
DNA-synthesis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
phosphoinositide	NULL
breakdown	NULL
.	NULL

Growth	NULL
Factors	NULL
,	NULL
2	NULL
:	NULL
289-300	NULL
,	NULL
1990	NULL
.	NULL

15	NULL
.	NULL

Imamura	NULL
,	NULL
K.	NULL
,	NULL
Dianoux	NULL
,	NULL
A.	NULL
,	NULL
Nakamura	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Colony-stimulating	NULL
factor	NULL
1	NULL
activates	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
:	NULL
2423-2429	NULL
,	NULL
1990	NULL
.	NULL

16	NULL
.	NULL

Orlofsky	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Stanley	NULL
,	NULL
E.	NULL
R.	NULL
CSF-1-induced	NULL
gene	NULL
expression	NULL
in	NULL
macrophages	NULL
:	NULL
dissociation	NULL
from	NULL
the	NULL
mitogenic	NULL
response	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
6	NULL
:	NULL
2947-2952	NULL
,	NULL
1987	NULL
.	NULL

17	NULL
.	NULL

Introna	NULL
,	NULL
M.	NULL
,	NULL
Bast	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Jr.	NULL
,	NULL
Johnson	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Adams	NULL
,	NULL
D.	NULL
O.	NULL
,	NULL
and	NULL
Hamilton	NULL
,	NULL
T.	NULL
A.	NULL
Homologous	NULL
and	NULL
heterologous	NULL
densitization	NULL
of	NULL
protooncogene	NULL
cFOS	NULL
expression	NULL
in	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
131	NULL
:	NULL
36-42	NULL
,	NULL
1987	NULL
.	NULL

18	NULL
.	NULL

Hamilton	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Veis	NULL
,	NULL
N.	NULL
,	NULL
Bordun	NULL
,	NULL
A-M.	NULL
,	NULL
Vairo	NULL
,	NULL
G.	NULL
,	NULL
Gonda	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Phillips	NULL
,	NULL
W.	NULL
A.	NULL
Activation	NULL
and	NULL
proliferation	NULL
signals	NULL
in	NULL
murine	NULL
macrophages	NULL
:	NULL
relationships	NULL
among	NULL
c-fos	NULL
and	NULL
c-myc	NULL
expression	NULL
,	NULL
phosphoinositide	NULL
hy-drolysis	NULL
,	NULL
superoxide	NULL
formation	NULL
,	NULL
and	NULL
DNA	NULL
synthesis	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
147	NULL
;	NULL
618-626	NULL
,	NULL
1989	NULL
.	NULL

19	NULL
.	NULL

Muller	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Muller	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Gilbert	NULL
,	NULL
L.	NULL
Induction	NULL
of	NULL
cfos	NULL
during	NULL
myelomonocytic	NULL
differentiation	NULL
and	NULL
macrophage	NULL
proliferation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
314	NULL
:	NULL
546-548	NULL
,	NULL
1985	NULL
.	NULL

271	NULL
272	NULL
M-CSF	NULL
Induces	NULL
jun	NULL
and	NULL
fos	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
Monocytes	NULL
20	NULL
.	NULL

Sariban	NULL
,	NULL
E.	NULL
,	NULL
Mitchell	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
Expression	NULL
of	NULL
the	NULL
c-fms	NULL
proto-oncogene	NULL
during	NULL
human	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
316	NULL
:	NULL
64-66	NULL
,	NULL
1985	NULL
.	NULL

21	NULL
.	NULL

Mitchell	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Zokas	NULL
,	NULL
L.	NULL
,	NULL
Schreiber	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
Rapid	NULL
induction	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
proto-oncogene	NULL
fos	NULL
during	NULL
human	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Cell	NULL
,	NULL
40	NULL
:	NULL
209-217	NULL
,	NULL
1985	NULL
.	NULL

22	NULL
.	NULL

Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Cohen	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
Bohmann	NULL
,	NULL
D.	NULL
,	NULL
Tjian	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
Fos-associated	NULL
protein	NULL
p39	NULL
is	NULL
the	NULL
product	NULL
of	NULL
the	NULL
jun	NULL
proto-oncogene	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
240	NULL
:	NULL
1010-1016	NULL
,	NULL
1988	NULL
.	NULL

23	NULL
.	NULL

Quantin	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Breathnach	NULL
,	NULL
R.	NULL
Epidermal	NULL
growth	NULL
factor	NULL
stimulates	NULL
transcription	NULL
of	NULL
c-jun	NULL
proto-oncogene	NULL
in	NULL
rat	NULL
fibroblasts	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
334	NULL
:	NULL
538-539	NULL
,	NULL
1988	NULL
.	NULL

24	NULL
.	NULL

Brenner	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
O'Hara	NULL
,	NULL
M.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Chojikier	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Prolonged	NULL
activation	NULL
of	NULL
jun	NULL
and	NULL
collagenase	NULL
genes	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
337	NULL
:	NULL
661-663	NULL
,	NULL
1989	NULL
.	NULL

25	NULL
.	NULL

Wu	NULL
,	NULL
B-Y	NULL
.	NULL

,	NULL
Fodor	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Edwards	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J.	NULL
Nerve	NULL
growth	NULL
factor	NULL
induces	NULL
the	NULL
proto-oncogene	NULL
c-jun	NULL
in	NULL
PC12	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
264	NULL
:	NULL
9000-9003	NULL
,	NULL
1989	NULL
.	NULL

26	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
,	NULL
Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
245	NULL
:	NULL
371-378	NULL
,	NULL
1989	NULL
.	NULL

27	NULL
.	NULL

Zerial	NULL
,	NULL
M.	NULL
,	NULL
Toschi	NULL
,	NULL
L.	NULL
,	NULL
Ryseck	NULL
,	NULL
R-P.	NULL
,	NULL
Schuermann	NULL
,	NULL
M.	NULL
,	NULL
Muller	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
The	NULL
product	NULL
of	NULL
a	NULL
novel	NULL
growth	NULL
factor	NULL
activated	NULL
gene	NULL
,	NULL
fos	NULL
B	NULL
,	NULL
interacts	NULL
with	NULL
JUN	NULL
proteins	NULL
enhancing	NULL
their	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
8	NULL
:	NULL
805-813	NULL
,	NULL
1989	NULL
.	NULL

28	NULL
.	NULL

Nakabeppu	NULL
,	NULL
Y.	NULL
,	NULL
Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
three	NULL
murine	NULL
Jun	NULL
proteins	NULL
:	NULL
stimulation	NULL
by	NULL
Fos	NULL
.	NULL

Cell	NULL
,	NULL
55	NULL
:	NULL
907-915	NULL
,	NULL
1988	NULL
.	NULL

29	NULL
.	NULL

Halazonetis	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Leder	NULL
,	NULL
P.	NULL
c-jun	NULL
dimerizes	NULL
itself	NULL
and	NULL
with	NULL
c-fos	NULL
,	NULL
forming	NULL
complexes	NULL
of	NULL
different	NULL
DNA	NULL
binding	NULL
affinities	NULL
.	NULL

Cell	NULL
,	NULL
55	NULL
:	NULL
917-924	NULL
,	NULL
1988	NULL
.	NULL

30	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lau	NULL
,	NULL
L.	NULL
F.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
A	NULL
gene	NULL
activated	NULL
by	NULL
growth	NULL
factors	NULL
is	NULL
related	NULL
to	NULL
the	NULL
oncogene	NULL
v-jun	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
,	NULL
USA	NULL
,	NULL
85	NULL
:	NULL
1487-1491	NULL
,	NULL
1988	NULL
.	NULL

31	NULL
.	NULL

Chiu	NULL
,	NULL
R.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Jun-B	NULL
differs	NULL
in	NULL
its	NULL
biological	NULL
properties	NULL
from	NULL
,	NULL
and	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
,	NULL
c-jun	NULL
.	NULL

Cell	NULL
,	NULL
59	NULL
:	NULL
979-986	NULL
,	NULL
1989	NULL
.	NULL

32	NULL
.	NULL

Schutte	NULL
,	NULL
J.	NULL
,	NULL
Viallet	NULL
,	NULL
J.	NULL
,	NULL
Nau	NULL
,	NULL
M.	NULL
,	NULL
Segal	NULL
,	NULL
S.	NULL
,	NULL
Fedorko	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Minna	NULL
,	NULL
J.	NULL
jun-B	NULL
inhibits	NULL
and	NULL
c-fos	NULL
stimulates	NULL
the	NULL
transforming	NULL
and	NULL
trans-activating	NULL
activities	NULL
of	NULL
c-jun	NULL
.	NULL

Cell	NULL
,	NULL
59	NULL
:	NULL
987-997	NULL
,	NULL
1989	NULL
.	NULL

33	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Stone	NULL
,	NULL
R.	NULL
,	NULL
Datta	NULL
,	NULL
R.	NULL
,	NULL
Bernstein	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Transcriptional	NULL
and	NULL
posttranscriptional	NULL
regulation	NULL
of	NULL
c-jun	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
:	NULL
3320-3323	NULL
,	NULL
1990	NULL
.	NULL

34	NULL
.	NULL

Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Freedman	NULL
,	NULL
A.	NULL
,	NULL
Kanakura	NULL
,	NULL
Y.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Ernst	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Griffith	NULL
,	NULL
J.	NULL
D.	NULL
Expression	NULL
and	NULL
state	NULL
of	NULL
phosphorylation	NULL
of	NULL
the	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
product	NULL
in	NULL
cycling	NULL
and	NULL
noncycling	NULL
human	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
:	NULL
2770-2774	NULL
,	NULL
1990	NULL
.	NULL

35	NULL
.	NULL

Nedwin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Svedersky	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Bringman	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Palladino	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
Effect	NULL
of	NULL
interleukin	NULL
2	NULL
,	NULL
interferon-gamma	NULL
,	NULL
and	NULL
mito-gens	NULL
on	NULL
the	NULL
production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factors	NULL
alpha	NULL
and	NULL
beta	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
135	NULL
;	NULL
2492-2497	NULL
,	NULL
1985	NULL
.	NULL

36	NULL
.	NULL

Sariban	NULL
,	NULL
E.	NULL
,	NULL
Imamura	NULL
,	NULL
K.	NULL
,	NULL
Luebbers	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Transcriptional	NULL
and	NULL
posttranscriptional	NULL
regulation	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
81	NULL
:	NULL
1506-1510	NULL
,	NULL
1988	NULL
.	NULL

37	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
Induction	NULL
of	NULL
protooncogene	NULL
c-jun	NULL
by	NULL
serum	NULL
growth	NULL
factors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
:	NULL
8464-8467	NULL
,	NULL
1988	NULL
.	NULL

38	NULL
.	NULL

Bertani	NULL
,	NULL
A.	NULL
,	NULL
Polentarutti	NULL
,	NULL
N.	NULL
,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
Rambaldi	NULL
,	NULL
A.	NULL
,	NULL
Mantovani	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Colotta	NULL
,	NULL
F.	NULL
Expression	NULL
of	NULL
c-jun	NULL
protooncogene	NULL
in	NULL
human	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
74	NULL
:	NULL
1811-1816	NULL
,	NULL
1989	NULL
.	NULL

39	NULL
.	NULL

Kouzarides	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ziff	NULL
,	NULL
E.	NULL
Leucine	NULL
zippers	NULL
of	NULL
fos	NULL
,	NULL
jun	NULL
,	NULL
and	NULL
GCN4	NULL
dictate	NULL
dimerization	NULL
specificity	NULL
and	NULL
thereby	NULL
control	NULL
DNA	NULL
binding	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
340	NULL
:	NULL
568-571	NULL
,	NULL
1988	NULL
.	NULL

40	NULL
.	NULL

Sariban	NULL
,	NULL
E.	NULL
,	NULL
Luebbers	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
Transcriptional	NULL
and	NULL
posttranscriptional	NULL
control	NULL
of	NULL
c-fos	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
340-346	NULL
,	NULL
1988	NULL
.	NULL

41	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lanahan	NULL
,	NULL
A.	NULL
,	NULL
Perez-Albuerne	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
Jun-D	NULL
:	NULL
a	NULL
third	NULL
member	NULL
of	NULL
the	NULL
Jun	NULL
gene	NULL
family	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
:	NULL
1500-1503	NULL
,	NULL
1989	NULL
.	NULL

42	NULL
.	NULL

Hirai	NULL
,	NULL
S-1	NULL
.	NULL

,	NULL
Ryseck	NULL
,	NULL
R-P.	NULL
,	NULL
Mechta	NULL
,	NULL
F.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Yaniv	NULL
,	NULL
M.	NULL
Characterization	NULL
of	NULL
jun-D	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
jun	NULL
proto-oncogene	NULL
family	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
8	NULL
:	NULL
1433-1439	NULL
,	NULL
1989	NULL
.	NULL

43	NULL
.	NULL

Cohen	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
fra-1	NULL
:	NULL
a	NULL
serum-inducible	NULL
,	NULL
cellular	NULL
im-mediate-early	NULL
gene	NULL
that	NULL
encodes	NULL
a	NULL
fos-related	NULL
antigen	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
:	NULL
2063-2069	NULL
,	NULL
1988	NULL
.	NULL

44	NULL
.	NULL

Cohen	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Ferreira	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Gentz	NULL
,	NULL
R.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
The	NULL
product	NULL
of	NULL
a	NULL
fos-related	NULL
gene	NULL
,	NULL
fra-1	NULL
,	NULL
binds	NULL
cooperatively	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
with	NULL
Jun	NULL
:	NULL
transcription	NULL
factor	NULL
AP-1	NULL
is	NULL
comprised	NULL
of	NULL
multiple	NULL
protein	NULL
complexes	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
:	NULL
173-184	NULL
,	NULL
1989	NULL
.	NULL

45	NULL
.	NULL

Sariban	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
PDGF-1	NULL
and	NULL
PDGF-2	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
and	NULL
monocytes	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
48	NULL
:	NULL
4498-4502	NULL
,	NULL
1988	NULL
.	NULL

46	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
,	NULL
18	NULL
:	NULL
5294-5299	NULL
,	NULL
1979	NULL
.	NULL

47	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Allegretto	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Okino	NULL
,	NULL
S.	NULL
,	NULL
Hattori	NULL
,	NULL
K.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Oncogene	NULL
jun	NULL
encodes	NULL
a	NULL
sequence-specific	NULL
transacti-vator	NULL
similar	NULL
to	NULL
AP-1	NULL
.	NULL

Nature	NULL
{	NULL
Lond	NULL
.	NULL
}	NULL

,	NULL
332	NULL
:	NULL
166-171	NULL
,	NULL
1988	NULL
.	NULL

48	NULL
.	NULL

Curran	NULL
,	NULL
T.	NULL
,	NULL
McConnell	NULL
,	NULL
W.	NULL
P.	NULL
,	NULL
Van-Straaten	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
Structure	NULL
of	NULL
the	NULL
FBJ	NULL
murine	NULL
osteosarcoma	NULL
virus	NULL
genome	NULL
:	NULL
molecular	NULL
cloning	NULL
of	NULL
its	NULL
associated	NULL
helper	NULL
virus	NULL
and	NULL
the	NULL
cellular	NULL
homolog	NULL
of	NULL
the	NULL
v-fos	NULL
gene	NULL
from	NULL
mouse	NULL
and	NULL
human	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
3	NULL
:	NULL
914-921	NULL
,	NULL
1983	NULL
.	NULL

49	NULL
.	NULL

Cleveland	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Lopata	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Cowan	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Rutter	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
Kirschner	NULL
,	NULL
M.	NULL
W.	NULL
Number	NULL
and	NULL
evolutionary	NULL
conservation	NULL
of	NULL
alpha-	NULL
and	NULL
beta-tubulin	NULL
and	NULL
cytoplasmic	NULL
beta-	NULL
and	NULL
gamma-actin	NULL
genes	NULL
using	NULL
specific	NULL
cloned	NULL
cDNA	NULL
probes	NULL
.	NULL

Cell	NULL
,	NULL
20	NULL
:	NULL
95-105	NULL
,	NULL
1980	NULL
.	NULL

50	NULL
.	NULL

Wang	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Creasey	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Ladner	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Lin	NULL
,	NULL
L-S.	NULL
,	NULL
Strickler	NULL
,	NULL
J.	NULL
,	NULL
Van	NULL
Arsdell	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Yamamoto	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Mark	NULL
,	NULL
D.	NULL
F.	NULL
Molecular	NULL
cloning	NULL
of	NULL
the	NULL
complementary	NULL
DNA	NULL
for	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
228	NULL
:	NULL
149-154	NULL
,	NULL
1985	NULL
.	NULL

51	NULL
.	NULL

Derynck	NULL
,	NULL
R.	NULL
,	NULL
Jarrett	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Chen	NULL
,	NULL
E.	NULL
Y.	NULL
,	NULL
Eaton	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Bell	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Assoian	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Roberts	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Sporn	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
Human	NULL
transforming	NULL
growth	NULL
factor-8	NULL
complementary	NULL
DNA	NULL
sequence	NULL
and	NULL
expression	NULL
in	NULL
normal	NULL
and	NULL
transformed	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
316	NULL
:	NULL
701-705	NULL
,	NULL
1985	NULL
.	NULL

